AXCELLA
Axcella is a clinical-stage biotechnology company that treats complex diseases using endogenous metabolic modulator (EMM) compositions. They combine biological pathways with developments in systems biology and machine learning. Their proprietary platform is clinically validated across several indication areas, with clinical-stage candidates in muscle, neurodegenerative, and liver conditions.
AXCELLA
Industry:
Biotechnology Life Science Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.axcellatx.com
Total Employee:
51+
Status:
Active
Contact:
+1 617 441 6243
Total Funding:
185.5 M USD
Technology used in webpage:
Akamai Hosted
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Again Life U.S.A.
Again Life U.S.A. is a pharmaceutical biotechnology company that provides research and the development of its biotechnological platform.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Enveda Biosciences
Enveda Biosciences is a biotechnology company building new medicines from plants.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
TCR2
TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.
Young Therapeutics
Young Therapeutics is a biotechnology company that treats ischemia or reperfusion injury.
Current Advisors List
Board_member
2009-01-01
Advisor
Advisor
Board_member
Advisor
Advisor
Advisor
Board_member
Current Employees Featured
David Epstein Chairman Of The Board @ Axcella
Chairman Of The Board
2017-12-01
Heidy King-Jones Senior Vice President, General Counsel & Corporate Secretary @ Axcella
Senior Vice President, General Counsel & Corporate Secretary
2019-11-01
Tony Tramontin Senior Vice President of Research & Development, Chief Scientific Officer @ Axcella
Senior Vice President of Research & Development, Chief Scientific Officer
2017-06-01
David Berry Founder @ Axcella
Founder
2009-01-01
Paul Fehlner Senior Vice President & Chief Intellectual Property Officer @ Axcella
Senior Vice President & Chief Intellectual Property Officer
2018-04-01
Jeff Moore CFO @ Axcella
CFO
2011-08-01
Geoffrey von Maltzahn Co-Founder @ Axcella
Co-Founder
2009-01-01
Laurent Chardonnet Senior Vice President & Chief Financial Officer @ Axcella
Senior Vice President & Chief Financial Officer
2019-11-01
Shreeram Aradhye Chief Development Officer and Board Member @ Axcella
Chief Development Officer and Board Member
2019-05-01
Stephen Mitchener Senior Vice President & Chief Business Officer @ Axcella
Senior Vice President & Chief Business Officer
2018-09-01
Founder
Stock Details
Investors List
Fidelity
Fidelity investment in Series E - Axcella
Nestlé Health Science
Nestlé Health Science investment in Series E - Axcella
Flagship Pioneering
Flagship Pioneering investment in Series E - Axcella
Nestlé Health Science
Nestlé Health Science investment in Series D - Axcella
Fidelity
Fidelity investment in Series C - Axcella
Rajiv Kaul
Rajiv Kaul investment in Series C - Axcella
Flagship Pioneering
Flagship Pioneering investment in Series C - Axcella
Enso Ventures
Enso Ventures investment in Series B - Axcella
Flagship Pioneering
Flagship Pioneering investment in Series B - Axcella
Flagship Pioneering
Flagship Pioneering investment in Series A - Axcella
Official Site Inspections
http://www.axcellatx.com Semrush global rank: 574.41 K Semrush visits lastest month: 56.64 K
- Host name: 104.21.78.249
- IP address: 104.21.78.249
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Axcella"
Axcella - Crunchbase Company Profile & Funding
Axcella is a clinical-stage biotechnology company that treats complex diseases using endogenous metabolic modulator (EMM) compositions. They combine biological pathways with developments in systems biology and machine learning.See details»
Axcella - LinkedIn
Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using endogenous metabolic modulator (EMM) compositions.See details»
Axcella Overview | SignalHire Company Profile
Organization Website. axcellatx.com . Social Links. Contact Email [email protected] Phone Number. 857-320-2200,617-441-6243. Axcella industries. Biotech, Biotechnology …See details»
Working At Axcella: Company Overview and Culture - Zippia
Mar 14, 2024 axcellatx.com. Organization Type. Public. Social Media. Axcella Health is pioneering revolutionary new medicines with a focus on amino acid homeostasis. The …See details»
Axcella - Overview, News & Similar companies | ZoomInfo.com
Oct 29, 2023 View Axcella (www.axcellatx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Axcella Announces Program Reprioritization and Corporate …
Dec 15, 2022 Axcella is realigning the organization to correspond to this shift in strategy and reprioritization of its programs, reducing its workforce by 85 percent, retaining certain …See details»
Axcella Therapeutics - VentureRadar
Website: https://axcellatx.com/ Develops multi-targeted endogenous metabolic modulator (EMM) compositions to address complex diseases by leveraging systems biology ...See details»
Axcella Therapeutics - VentureRadar
Open PageRank: 4,375,078 | axcellatx.com. VentureRadar Popularity. Medium. VentureRadar Popularity: Medium. The popularity score combines profile views, clicks and the number of …See details»
Axcella - Golden
Axcella is a clinical-stage biotechnology company that is pioneering a new approach of treating complex diseases and improving health using endogenous metabolic modulator compositions.See details»
Axcella Therapeutics - Flagship Pioneering
Founded by Flagship Pioneering in 2011, Axcella is a biotechnology company pioneering a new way to harness the power of endogenous metabolic modulators, or EMMs, with the goals of …See details»
Axcella Announces FDA IND Clearance Supporting Regulatory …
Feb 15, 2023 The forum is co-sponsored by the Biotechnology Innovation Organization (BIO) and SOLVE M.E., a non-profit organization that serves as a catalyst for critical research into …See details»
Axcella Therapeutics Announces $34.2 Million Registered Direct …
Oct 13, 2022 Prior to joining Flagship, Mr. Straight Nissen headed up Strategic Portfolio Management for Pfizer's worldwide R&D organization where he oversaw Pfizer's portfolio …See details»
Flagship-founded Axcella folds - Fierce Biotech
Dec 5, 2023 Flagship-founded Axcella Health is closing its doors, with stockholders approving the dissolution of the metabolic modulator biotech yesterday.. Founded by Flagship Pioneering …See details»
Robert Crane - Chief Financial Officer at Axcella | ZoomInfo
Robert Crane’s email address is r***@axcellatx.com What is Robert Crane’s business email address? ... Robert Crane serves as Chief Financial Officer for the organization. Mr. Crane …See details»
Güvenilir Bahis Siteleri ️
Güvenilir ve avantajlı bahisler sunan en iyi ve en güvenli bahis siteleri. Bahis sitemizi ziyaret ederek önde gelen Türk bahisçilerinden birini deneyimleyinSee details»
Axcella Therapeutics Details Clinical and Operational Milestones …
Jan 6, 2022 Jason Fredette jfredette@axcellatx.com (857) 320-2236 Site Navigation. Home. Home; Submit a Press Release; Services; News. All News; News with Multimedia; News by …See details»
Axcella Announces Program Reprioritization and Corporate …
Dec 14, 2022 Detailed price information for Axcella Health Inc (AXLA) from The Globe and Mail including charting and trades.See details»
Teach For America Names Aneesh Sohoni New Chief Executive …
13 hours ago Teach For America (TFA), the nonprofit organization that finds, develops and supports exceptional, diverse leaders committed to ensuring all children have the opportunity …See details»
Axcella Therapeutics Announces $25 Million Registered Direct …
Mar 16, 2022 Company Jason Fredette jfredette@axcellatx.com (857) 320-2236 Site Navigation. Home. Home; Submit a Press Release; Services; News. All News; News with Multimedia; …See details»
View of U.S. Healthcare Quality Declines to 24-Year Low
Dec 6, 2024 Editor's Note: This research was conducted in partnership with West Health, a family of nonprofit and nonpartisan organizations focused on healthcare and aging.. …See details»